Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.

OBJECTIVE To validate a published model for the prediction of the individual FSH response dose for gonadotropin induction of ovulation in polycystic ovary syndrome (PCOS). DESIGN Structured, complete, and carefully monitored patient-based data collection to test the external validity of the prediction model. SETTING Twenty-nine hospitals in The Netherlands. PATIENT(S) Eighty-five clomiphene citrate (CC)-resistant women with PCOS. INTERVENTION(S) Ovulation induction in a chronic low-dose step-up FSH regimen. MAIN OUTCOME MEASURE(S) Predicted individual FSH response dose, defined as follicle growth >10 mm in diameter on ultrasound. RESULT(S) The model, using the women's body mass index, CC response, initial serum FSH level, and initial serum insulin-to-glucose ratio was studied in the validation sample. Overall, the FSH response dose predicted by the model was higher than the observed response dose. The predictive performance of the model was poor, with an R(2) of 0.11, and the average prediction error was 35 IU. CONCLUSION(S) The external validity of the model predicting the individual FSH response dose was inadequate in women with CC-resistant PCOS undergoing ovulation induction with recombinant FSH in a low-dose step-up regimen.

[1]  B. Fauser,et al.  Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. , 1997, The Journal of clinical endocrinology and metabolism.

[2]  S. Christin‐Maitre,et al.  A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. , 2003, Human reproduction.

[3]  E. Diamanti-Kandarakis,et al.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.

[4]  J. L. San Millán,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .

[5]  T. Key,et al.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.

[6]  R. Casamitjana,et al.  Recombinant Human Follicle-Stimulating Hormone for Ovulation Induction in Polycystic Ovary Syndrome: A Prospective, Randomized Trial Of Two Starting Doses in a Chronic Low-Dose Step-up Protocol , 2000, Journal of Assisted Reproduction and Genetics.

[7]  R. Homburg,et al.  Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. , 1999, Human reproduction update.

[8]  P. Devroey,et al.  Multiple birth resulting from ovarian stimulation for subfertility treatment , 2005, The Lancet.

[9]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[10]  B. Fauser,et al.  Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. , 1995, Human reproduction.

[11]  James B. Brown,et al.  Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy , 1978, The Australian & New Zealand journal of obstetrics & gynaecology.

[12]  J. Habbema,et al.  Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. , 1998, The Journal of clinical endocrinology and metabolism.

[13]  R. Homburg Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[14]  Marinus J C Eijkemans,et al.  A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. , 2002, Fertility and sterility.

[15]  S. Franks,et al.  Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. , 1996, The Journal of clinical endocrinology and metabolism.

[16]  P. J. Rowe,et al.  WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple , 1993 .

[17]  M. Eijkemans,et al.  Patient-tailored conventional ovulation induction algorithms in anovulatory infertility , 2005, Trends in Endocrinology & Metabolism.

[18]  L. Giudice,et al.  Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. , 2002, Fertility and sterility.

[19]  J. Habbema,et al.  High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). , 2003, Human reproduction.

[20]  M. Aboulghar,et al.  Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. , 2003, Human reproduction update.

[21]  Jesse A. Berlin,et al.  Assessing the Generalizability of Prognostic Information , 1999 .

[22]  Serge Rozenberg,et al.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. , 2002, Human reproduction update.

[23]  P. Bossuyt,et al.  Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial , 2004, BMJ : British Medical Journal.

[24]  B. Fauser,et al.  Manipulation of human ovarian function: physiological concepts and clinical consequences. , 1997, Endocrine reviews.

[25]  M. Hull Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[26]  W. Hop,et al.  Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. , 1995, Fertility and sterility.

[27]  P. Claman Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[28]  F. Veen,et al.  Urofollitropin and Ovulation Induction , 2005, Treatments in endocrinology.